Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tocca Life Holdings Inc (TLIF)
Winter Park, FL, US
Central Asia Lumeichun Biotechnology Inc. operates sober living residences in the United States. It offers life coaching programs through the provision of equipment, materials, and demonstrations, including cooking, cleaning, household maintenance, basic math and banking, computer and writing skills, life coaching, transitional living management, graphic art, information technology, marketing, television production, interest rate theories, credit cost valuation, mortgage banking, and business etiquette, models, infrastructures, and ethics, as well as entrepreneurship and sports events and fitness. The company was formerly known as TOCCA Life Holdings, Inc. and changed its name to Central Asia Lumeichun Biotechnology Inc. in October 2025. The company is based in Winter Park, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00% | +0.00% | -6.00% | +17.50% | -6.00% | -6.00% | +23.68% | -80.42% | -92.99% | -76.50% | -99.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+30.2% ★ Q1'26: +72.3% (vs Q2'24)
-
EPS growth Medical - Care Facilities: +19.2%+100.0% ★ Q1'26: +100.0% (vs Q2'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+57.1% Q1'26: +215.2% (vs Q2'24)
-
EBIT margin Medical - Care Facilities: +11.3%+0.7% Q1'26: +3.0% (vs Q2'24)
-
ROIC Medical - Care Facilities: +6.8%+0.4% Q1'26: +3.3% (vs Q2'24)
-
Share dilution Medical - Care Facilities: +0.0%+43.9% Q1'26: +194.3% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.69× Q1'26: 0.19× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2007 actual |
Dec 2008 actual |
|---|---|---|
| Revenue |
35.24M
est: 53.37M (-34.0%)
|
45.68M
est: 110.18M (-58.5%)
|
| EBITDA |
19.37M
est: -4.72M (+510.7%)
|
-3.45M
est: -9.73M (+64.6%)
|
| EBIT |
18.40M
est: -5.56M (+430.9%)
|
-4.42M
est: -11.48M (+61.5%)
|
| Net Income |
12.20M
|
14.55M
|
| SGA |
3.30M
est: 64.14M (-94.9%)
|
3.92M
est: 132.41M (-97.0%)
|
| EPS |
—
|
24,216.00
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stephen W. Carnes | Chief Executive Officer, Chief Financial Officer, Secretary & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TLIF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
